ARCHIVES

ODAC Recommends Approval of Evista for Breast Cancer Risk Reduction.

This article is from The Cancer Letter archive.

Vol. 33 No. 29 | July 27, 2007

Download PDF Visit The Full Archive

Related Articles

Managed Care Plans Seek Cost Efficacy, Not Research, Center Directors Warned

March 17, 1995

NCI To Establish New Offices for Special Populations, Survivorship, Klausner Tells House appropirations Subcommittee

May 3, 1996

NCI Cooperative Group, Cancer Center Trials Listed

May 30, 2008

NCAB Approves Addition Of Two New Organ Systems

February 14, 1986

Medenica Granted Extension Of Privileges At Hilton Head Hospital

November 26, 1993

DCE Proposes AIDS-Cancer Registry For Funding Through $2 Mil. Contract

April 9, 1993